H. pylori infection and atrophic gastritis diagnosis

The non-invasive GastroPanel examination diagnoses H. pylori infection as well as atrophic gastritis and its location. It also reveals if risk of gastroesophageal reflux disease is increased due to high stomach acid secretion.

The examination four biomarkers in blood: pepsinogen I and II, gastrin-17 and H. pylori antibodies. It is designed for use as a primary and follow-up examination in the diagnosis and treatment of patients with dyspepsia, H. pylori infection, atrophic gastritis and related risks. If the GastroPanel examination gives a normal result, the diagnosis is either functional dyspepsia or another disease not involving the gastric mucosa. GastroSoft interpretation software shows the test results, reference ranges and diagnosis and, when necessary, also gives recommendation on possible treatment or further testing. The GastroSoft report also indicates if there is an increased risk of gastroesophageal reflux disease.